{"goal": [[" The aim of our study was to identify the cerebral correlates of neuropsychological deficits as assessed by the CERAD-NP test battery in a large sample including healthy subjects and both, patients with MCI and AD.", {"pattern": {"sp_index": 0, "sub": ["aim"], "pred": ["was"], "nes": {"MCI": 1}, "cds": {}}, "sp": 14, "ne": 54, "cd": 0, "sid": "15", "total": 68, "doc_id": "./anns_v2/Dos Santos et al., (2011) - Morphological cerebral correlates of CERAD test performance in AD and MCI_annotated_ann.json"}], ["The aim of the present study was to examine the relationship between cerebral morphological changes and cognitive deficits as determined by the CERAD neuropsychological test battery in a large group of patients with MCI and with AD and otherwise healthy elderly controls.", {"pattern": {"sp_index": 0, "sub": ["aim"], "pred": ["was"], "nes": {"CERAD": 1, "AD": 1, "MCI": 1}, "cds": {}}, "sp": 14, "ne": 98, "cd": 0, "sid": "40", "total": 112, "doc_id": "./anns_v2/Dos Santos et al., (2011) - Morphological cerebral correlates of CERAD test performance in AD and MCI_annotated_ann.json"}]], "findings": [[" When compared to the healthy controls, the AD patients and, to a lesser extent, patients with MCI showed significant density losses predominantly in the medial temporal lobe.", {"pattern": {"sp_index": 115, "sub": ["patients"], "pred": ["showed"], "nes": {"MCI": 1}, "cds": {}}, "sp": 2, "ne": 54, "cd": 0, "sid": "4", "total": 56, "doc_id": "./anns_v2/Dos Santos et al., (2011) - Morphological cerebral correlates of CERAD test performance in AD and MCI_annotated_ann.json"}], [" In conclusion, we found impaired cognitive performance as assessed with the CERAD test battery to be associated with reduced gray matter densities in a variety of cerebral sites, likely reflecting the fact that cognitive impairment in AD and in its presumable precursor MCI is not simple related to degenerative processes in a few distinct brain regions.", {"pattern": {"sp_index": 14, "sub": ["we"], "pred": ["found"], "nes": {"CERAD": 1, "AD": 1, "MCI": 1}, "cds": {}}, "sp": 5, "ne": 98, "cd": 0, "sid": "63", "total": 103, "doc_id": "./anns_v2/Dos Santos et al., (2011) - Morphological cerebral correlates of CERAD test performance in AD and MCI_annotated_ann.json"}]], "method": [[" Sixty patients with MCI, 34 patients with mild to moderate AD, and 32 healthy controls underwent both extensive neuropsychological assessment (CERAD test battery) and high-resolution structural magnetic resonance imaging.", {"pattern": {"sp_index": 22, "sub": ["patients"], "pred": ["underwent"], "nes": {"CERAD": 1, "MCI": 1}, "cds": {"patients": 2, "controls": 1}}, "sp": 5, "ne": 67, "cd": 140, "sid": "2", "total": 212, "doc_id": "./anns_v2/Dos Santos et al., (2011) - Morphological cerebral correlates of CERAD test performance in AD and MCI_annotated_ann.json"}], [" Similarly, a recent FDG-PET study which involved 30 patients in all stages of AD identified the left temporal posterior cortex as an important site for naming deficits [9].", {"pattern": {"sp_index": -1, "sub": ["study"], "pred": ["identified"], "nes": {"AD": 1}, "cds": {"patients": 1, "]": 1}}, "sp": 0, "ne": 31, "cd": 126, "sid": "51", "total": 157, "doc_id": "./anns_v2/Dos Santos et al., (2011) - Morphological cerebral correlates of CERAD test performance in AD and MCI_annotated_ann.json"}]]}